Plasma Cell Priming
Plasma Cell Priming
批准号:
9403332
负责人:
David M Allman
金额:
$24.15万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-06-01 至 2019-05-31
关键词:
AddressAntibodiesApoptoticAutoantibodiesAutoimmune DiseasesAutoimmunityAutomobile DrivingB cell differentiationB-LymphocytesBCL1 OncogeneBacteriaBiochemicalBiochemical PathwayBiological MarkersBloodCell CountCell divisionCellsCouplesCuesDataEnsureEvaluationEventFRAP1 geneFamilyGene DeletionGene ExpressionGene Expression ProfileGene Expression RegulationGenerationsGenesGoalsHost DefenseImmunityIn SituKineticsKnowledgeLupusMediatingMitosisMolecularPathogenicityPhasePhosphotransferasesPlasma CellsPlayPopulationPositioning AttributeProcessProteinsReceptor SignalingRestRoleSignal PathwaySignal TransductionSinusSpleenTSC1 geneTestingTherapeuticTranscriptTransgenesTranslatingTranslationsUp-RegulationWorkXBP1 geneadenoviral-mediatedcombatcytokinedifferentiated B cellexperimental studyextracellularin vitro Modelin vivoinsightmTOR inhibitionnovel strategiesplasma cell differentiationprogramsreceptorreceptor expressionresponsetranscription factortranscriptome sequencing
中文摘要
项目总结
英文摘要
Project summary
The cellular and molecular events underlying the generation of self-reactive antibodies in
autoimmunity remain poorly understood. Notably, marginal zone (MZ) B cells are
enriched for self-reactive B cells, and are known to generate antibody-secreting plasma
cells exceptionally quickly compared to other B cells. This R21 project centers on
understanding the molecular mechanisms through which MZ B cells generate plasma
cells with accelerated kinetics, with a focus on defining extracellular cues and associated
intracellular signaling pathways that prime MZ B cells for differentiation. The central
hypothesis guiding this work is that the mTOR/mTORC1 kinase, an emerging biomarker
in lupus and related autoimmune diseases, couples BAFF-receptor signaling and
expression of relevant plasma cell genes to facilitate rapid induction of antibody
synthesis. To test this hypothesis we will: 1) Define the role of mTOR/mTORC1 signaling
in plasma cell priming, and 2) Explore the identity of extracellular inputs driving plasma
cell priming in situ. These studies will enhance knowledge of the processes underlying
the generation of all plasma cells including those secreting pathogenic self-reactive
antibodies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Biochemical Mechanisms for Sustained Humoral Immunity
-
批准号:10637251
-
项目类别:
-
资助金额:$64.81万
-
财政年份:2023
-
负责人:David M Allman
-
依托单位:
The Notch Pathway in Antigen Design
-
批准号:10575892
-
项目类别:
-
资助金额:$26.4万
-
财政年份:2023
-
负责人:David M Allman
-
依托单位:
Plasma Cell Regulation by Purinergic Receptors
-
批准号:10441466
-
项目类别:
-
资助金额:$20.31万
-
财政年份:2021
-
负责人:David M Allman
-
依托单位:
Plasma Cell Regulation by Purinergic Receptors
-
批准号:10240081
-
项目类别:
-
资助金额:$24.38万
-
财政年份:2021
-
负责人:David M Allman
-
依托单位:
Proteasome targeting for alloreactive plasma cells
-
批准号:10215534
-
项目类别:
-
资助金额:$69.17万
-
财政年份:2020
-
负责人:David M Allman
-
依托单位:
Proteasome targeting for alloreactive plasma cells
-
批准号:10443660
-
项目类别:
-
资助金额:$68.88万
-
财政年份:2020
-
负责人:David M Allman
-
依托单位:
Proteasome targeting for alloreactive plasma cells
-
批准号:10652461
-
项目类别:
-
资助金额:$65.66万
-
财政年份:2020
-
负责人:David M Allman
-
依托单位:
Epigenetic Control of Plasma Cell Differentiation
-
批准号:9105812
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2015
-
负责人:David M Allman
-
依托单位:
Origins of serum IgA antibodies
-
批准号:9111850
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2014
-
负责人:David M Allman
-
依托单位:
Origins of serum IgA antibodies
-
批准号:9315100
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2014
-
负责人:David M Allman
-
依托单位:
Origins of serum IgA antibodies
-
批准号:8772548
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2014
-
负责人:David M Allman
-
依托单位:
Long-lived CD19-positive plasma cells
-
批准号:8387887
-
项目类别:
-
资助金额:$38.93万
-
财政年份:2012
-
负责人:David M Allman
-
依托单位:
Long-lived CD19-positive plasma cells
-
批准号:8508182
-
项目类别:
-
资助金额:$36.64万
-
财政年份:2012
-
负责人:David M Allman
-
依托单位:
Long-lived CD19-positive plasma cells
-
批准号:8680129
-
项目类别:
-
资助金额:$39.01万
-
财政年份:2012
-
负责人:David M Allman
-
依托单位:
Long-lived CD19-positive plasma cells
-
批准号:9096003
-
项目类别:
-
资助金额:$39.07万
-
财政年份:2012
-
负责人:David M Allman
-
依托单位:
Long-lived CD19-positive plasma cells
-
批准号:8868901
-
项目类别:
-
资助金额:$39.04万
-
财政年份:2012
-
负责人:David M Allman
-
依托单位:
Long-lived antibody secreting cells
-
批准号:8066726
-
项目类别:
-
资助金额:$19.1万
-
财政年份:2010
-
负责人:David M Allman
-
依托单位:
Long-lived antibody secreting cells
-
批准号:7983146
-
项目类别:
-
资助金额:$23.14万
-
财政年份:2010
-
负责人:David M Allman
-
依托单位:
Aging of Early B Cell Precursors
-
批准号:7812028
-
项目类别:
-
资助金额:$30.42万
-
财政年份:2006
-
负责人:David M Allman
-
依托单位:
Aging of Early B Cell Precursors
-
批准号:7268827
-
项目类别:
-
资助金额:$28.2万
-
财政年份:2006
-
负责人:David M Allman
-
依托单位:
海外基金